Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $4,667 - $2.76 Million
-35,900 Reduced 97.03%
1,100 $78,000
Q2 2022

Aug 02, 2022

SELL
$72.62 - $79.98 $1.85 Million - $2.04 Million
-25,500 Reduced 40.8%
37,000 $2.85 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $2.77 Million - $3.32 Million
45,000 Added 257.14%
62,500 $4.56 Million
Q4 2021

Jan 18, 2022

BUY
$53.63 - $62.52 $928,925 - $1.08 Million
17,321 Added 9676.54%
17,500 $1.09 Million
Q3 2021

Oct 20, 2021

SELL
$59.17 - $69.31 $5,384 - $6,307
-91 Reduced 33.7%
179 $1.06 Million
Q2 2021

Jul 19, 2021

BUY
$61.91 - $67.42 $10,462 - $11,393
169 Added 167.33%
270 $1.8 Million
Q1 2021

Apr 14, 2021

SELL
$59.34 - $66.74 $179,681 - $202,088
-3,028 Reduced 96.77%
101 $638,000
Q4 2020

Feb 25, 2021

BUY
$57.74 - $65.43 $7,852 - $8,898
136 Added 4.54%
3,129 $194,000
Q3 2020

Oct 19, 2020

SELL
$57.43 - $63.64 $8,327 - $9,227
-145 Reduced 4.62%
2,993 $18 Million
Q2 2020

Aug 06, 2020

SELL
$54.82 - $64.09 $41,553 - $48,580
-758 Reduced 19.46%
3,138 $18.5 Million
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $116,603 - $169,451
-2,513 Reduced 39.21%
3,896 $21.7 Million
Q4 2019

Jan 13, 2020

BUY
$49.21 - $64.19 $190,393 - $248,351
3,869 Added 152.32%
6,409 $41.1 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $44,908 - $53,245
-1,050 Reduced 29.25%
2,540 $12.9 Million
Q2 2019

Jul 16, 2019

BUY
$44.62 - $49.34 $35,785 - $39,570
802 Added 28.77%
3,590 $16.3 Million
Q1 2019

May 09, 2019

BUY
$45.12 - $53.8 $123,899 - $147,734
2,746 Added 6538.1%
2,788 $13.3 Million
Q4 2018

Jan 23, 2019

BUY
$48.76 - $63.23 $2,047 - $2,655
42 New
42 $218,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.